Azer Scientific Incorporated v. Quidel Corporation

District Court, E.D. Pennsylvania·Decided July 20, 2023·No. 5:21-cv-02972·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA __________________________________________

AZER SCIENTIFIC INCORPORATED, : Plaintiff, : : v. : Civil No. 5:21-cv-02972-JMG : QUIDEL CORPORATION, : Defendant. : ______________________________________________ MEMORANDUM OPINION GALLAGHER, J. July 20, 2023 On March 25, 2021 Azer and Quidel entered into a contract for Azer to fill, cap, and manufacture reagent for 120 million two mL tubes over a period of twelve months at a price of $0.087975 per tube and a total contract price of $10,557.000.00. At trial starting on February 3, 2023, a jury considered whether there was a breach of contract and, if so, whether damages were warranted for the breach. Azer contended Quidel breached the Parties’ contract on June 21, 2021, when Quidel’s Hiva Ardalan informed Azer’s representatives Quidel would not perform the terms of the March 25, 2021 contract. On the other hand, Quidel averred it did not breach the contract and Azer could not perform the contract at the time of the alleged breach. During trial, Azer moved to preclude one of Quidel’s experts, Kristin Flanagan, who Quidel anticipated calling as an expert damages witness. And, upon the close of evidence, both Azer and Quidel moved for judgment as a matter of law under Federal Rule of Civil Procedure 50(a). On February 8, 2023, the jury found Quidel breached the contract and awarded Azer a damages award of $8,521,609.00. Azer then moved to alter judgment to include prejudgment interest from the time of breach under Pennsylvania law, as well as post-judgment interest under federal law.

For the following reasons, Azer’s Motion to Preclude Quidel’s Witness Flanagan (ECF No. 120) is denied as moot. Furthermore, Quidel’s Motion for Judgment as a Matter of Law (ECF No. 127) is denied; and Azer’s Motion for Judgment as a Matter of Law (ECF No. 128) is denied. Lastly, Azer’s Motion to Alter Judgment as to Inclusion of Pre- and Post-Judgment Interest (ECF No. 133) is granted. 1. FACTUAL BACKGROUND On March 25, 2021 Azer and Quidel entered into a contract for Azer to fill, cap, and

manufacture reagent for 120 million two mL tubes over a period of twelve months at a price of $0.087975 per tube and a total contract price of $10,557.000.00. See Mem. Op., ECF No. 103 at 12; see also Mem. Op., ECF No. 66 at 15-16. At trial, a jury considered whether there was a breach of contract and, if so, whether damages were warranted for the breach. Azer contended Quidel breached the Parties’ contract on June 21, 2021, when Quidel’s Hiva Ardalan informed Azer’s representatives Quidel would not perform the terms of the March 25, 2021 contract. See e.g., Jury Trial Day One Transcript, ECF

No. 137 at 56-57 (Mr. Schiller Opening Statement); Pl.’s Pretrial Mem., ECF No. 65 at 8 (“By June 21, Quidel had informed Azer that Quidel would not be moving forward with the project as outlined in the [P]arties[’][sic] March 25 agreement.”). To support their theory of breach and damages, Azer presented evidence in the form of fact and expert witnesses, including, inter alia, Reza Ardekani, Adam Ardekani, Hiva Ardalan, Matthias Szcepanek, and Jeffrey Buchakjian. On the other hand, Quidel averred it did not breach the contract. See e.g., Jury Trial Day One Transcript, ECF No. 136 at 118-19 (Mr. Schweder Opening Statement). Furthermore, Quidel contended Azer could not perform the contract at that time. See e.g. id. at 118 (Mr. Schweder Opening Statement). In support of their defenses and theories, Quidel proffered the following fact

witnesses, inter alia, Hiva Ardalan and Kyra Bader. On February 2, 2023, Azer moved to preclude one of Quidel’s experts, Kristin Flanagan, who Quidel anticipated calling as an expert damages witness. See Pl.’s Mot. To Preclude Quidel’s Expert Witness Flanagan, ECF No. 120; see also Def.’s Pretrial Mem., ECF No. 64 at 12. Azer moved to preclude portions of Ms. Flanagan’s testimony at trial, including testimony “(1) regarding the purported ‘indirect costs’ based upon an estimate provided to her by Kevin Richardson and Todd Manke; and (2) regarding her calculation of damages based upon the early

termination provision in the draft supply agreements.” ECF No. 120 at 1. Quidel did not ultimately proffer Ms. Flanagan as an expert at trial. Following the close of evidence and closing statements, both Azer and Quidel moved for judgment as a matter of law under Federal Rule of Civil Procedure 50(a). See Pl.’s Mot. For Judgment as a Matter of Law, ECF No. 127; Def.’s Mot. For Judgment as a Matter of Law, ECF No. 128. In its motion, Azer avers judgment of a matter of law is warranted in Azer’s favor

concerning (1) Quidel’s mitigation affirmative defense; (2) Quidel’s breach of contract and/or repudiation claim; and (3) Quidel’s breach of the March 25, 2021 contract. See generally ECF No. 127. On the other hand, Quidel submits judgment as a matter of law is warranted in its favor because no reasonable jury could find: (1) Quidel breached the March 25, 2021 contract; (2) Quidel anticipatorily breached the March 25, 2021 contract; nor that (3) Azer proved damages to the requisite degree of certainty. See generally ECF No. 128. On February 8, 2023, the jury was tasked with determining whether Quidel breached its March 25, 2021 contract with Azer, and if so, what amount of money damages, if any, Azer was entitled to receive minus any amount Azer could have avoided or reduced through mitigation efforts. See Verdict Form, ECF No. 132; see also Jury Trial Day Four Transcript, ECF No. 139 at

123 (providing Azer must prove “. . . Quidel absolutely and unequivocally refused to perform its duties under the contract . . . and Azer would have been able to fulfill its obligations under the contract.”) (Jury Instructions). The jury found Quidel breached the contract. ECF No. 132. And the jury provided a damages award of $8,521,609.00. See id. On February 13, 2023, Azer moved to alter judgment to include pre- and post-judgment interest. See Pl.’s Mot. to Alter Judgment, ECF No. 133. Presently before the Court is: (1) Azer’s Motion to Preclude Quidel’s Witness Flanagan;

Free access — add to your briefcase to read the full text and ask questions with AI

Azer Scientific Incorporated v. Quidel Corporation, (E.D. Pa. 2023).

Azer Scientific Incorporated v. Quidel Corporation (Azer Scientific Incorporated v. Quidel Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Franconia Associates v. United States
536 U.S. 129 (Supreme Court, 2002)
Dunn v. HOVIC
13 F.3d 58 (Third Circuit, 1993)
Palmgreen v. Palmer's Garage, Inc.
117 A.2d 721 (Supreme Court of Pennsylvania, 1955)
2401 Pennsylvania Avenue Corp. v. Federation of Jewish Agencies
489 A.2d 733 (Supreme Court of Pennsylvania, 1985)
McDermott v. Party City Corp.
11 F. Supp. 2d 612 (E.D. Pennsylvania, 1998)
Somerset Community Hospital v. Allan B. Mitchell & Associates, Inc.
685 A.2d 141 (Superior Court of Pennsylvania, 1996)
Nikole, Inc. v. Klinger
603 A.2d 587 (Superior Court of Pennsylvania, 1992)
Skretvedt v. E.I. DuPont De Nemours
372 F.3d 193 (Third Circuit, 2004)
Edwards v. Wyatt
330 F. App'x 342 (Third Circuit, 2009)
Krishnan v. Cutler Group, Inc.
171 A.3d 856 (Superior Court of Pennsylvania, 2017)